Julius Mwaiselage
Overview
Explore the profile of Julius Mwaiselage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
928
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meena S, Kosgei B, Soko G, Tingjun C, Chambuso R, Mwaiselage J, et al.
NPJ Vaccines
. 2025 Jan;
10(1):18.
PMID: 39870669
Tumor-derived exosomes (TDEs) mediate oncogenic communication, which modifies target cells to reinforce a tumor-promoting microenvironment. TDEs support cancer progression by suppressing anti-tumor immune responses, promoting metastasis, and conferring drug resistance....
2.
Lidenge S, Yalcin D, Bennett S, Ngalamika O, Kweyamba B, Mwita C, et al.
Viruses
. 2024 Mar;
16(3).
PMID: 38543814
Seasonal coronaviruses (HCoVs) are known to contribute to cross-reactive antibody (Ab) responses against SARS-CoV-2. While these responses are predictable due to the high homology between SARS-CoV-2 and other CoVs, the...
3.
Shash E, Soliman G, Al-Kharusi W, Yahia M, Mwaiselage J, Mesemo D, et al.
J Cancer Educ
. 2023 Nov;
38(6):1783-1785.
PMID: 37930582
No abstract available.
4.
Mrema A, Ngoma M, Josiah C, Lugina E, Mvungi N, Paul M, et al.
JCO Glob Oncol
. 2023 Sep;
9:e2200441.
PMID: 37738537
Purpose: Cervical cancer (CC) is the leading malignancy in Tanzania. Low-income countries are faced with double epidemics of HIV and CC. This study aimed to investigate how HIV and cancer...
5.
Privatt S, Braga C, Johnson A, Lidenge S, Berry L, Ngowi J, et al.
Cancer Metab
. 2023 Aug;
11(1):13.
PMID: 37653396
Background: Kaposi sarcoma (KS) is a neoplastic disease etiologically associated with infection by the Kaposi sarcoma-associated herpesvirus (KSHV). KS manifests primarily as cutaneous lesions in individuals due to either age...
6.
Fuss C, Msami K, Kahesa C, Mwaiselage J, Gordon A, Sohler N, et al.
Cancer Causes Control
. 2023 Aug;
35(1):93-101.
PMID: 37574489
Purpose: Reducing time between cancer screening, diagnosis, and initiation of treatment is best achieved when services are available in the same hospital. Yet, comprehensive cancer centers are typically unavailable in...
7.
Van Loon K, Mmbaga E, Mushi B, Selekwa M, Mwanga A, Akoko L, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Jul;
32(10):1411-1420.
PMID: 37505926
Background: Esophageal squamous cell carcinoma (ESCC) comprises 90% of all esophageal cancer cases globally and is the most common histology in low-resource settings. Eastern Africa has a disproportionately high incidence...
8.
Mwelange L, Mamuya S, Mwaiselage J, Bratveit M, Moen B
Int J Environ Res Public Health
. 2023 Feb;
20(4).
PMID: 36833998
Background: Cancer in Africa is an emerging public health problem that needs urgent preventive measures, particularly in workplaces where exposure to carcinogens may occur. In Tanzania, the incidence rate of...
9.
Swai P, Mgongo M, Leyaro B, Mwaiselage J, Mchome B, Kjaer S, et al.
BMC Womens Health
. 2023 Feb;
23(1):61.
PMID: 36774477
Background: Human papilloma virus (HPV) is a sexually transmitted infection causing more than 80% of cervical cancers. WHO recommends using of sensitive screening methods like HPV-testing to timely prevent future...
10.
Ngalamika O, Lidenge S, Mukasine M, Kawimbe M, Kamanzi P, Ngowi J, et al.
Int J Infect Dis
. 2022 Dec;
127:106-115.
PMID: 36516914
Objectives: To longitudinally compare SARS-CoV-2-specific T cell and humoral immune responses between convalescent individuals who are HIV-positive (HIV+) and HIV-negative (HIV-). Methods: We conducted enzyme-linked immunospots to determine the SARS-CoV-2-specific...